Remember meForgot password?
    Log in with Twitter
| Press Release

Free Post Earnings Research Report: MAXIMUS’ Revenues Grew 3%; EPS Surged 25%

Stock Monitor: International Seaways Post Earnings Reporting

LONDON, UK / ACCESSWIRE / March 14, 2018 / has just released a free earnings report on MAXIMUS, Inc. (NYSE: MMS). If you want access to this report all you need to do is sign up now by clicking the following link The Company reported its first quarter fiscal 2018 operating and financial results on February 08, 2018. The government health services provider topped earnings expectations, and also raised its fiscal 2018 earnings guidance. Register today and get access to over 1000 Free Research Reports by joining our site below: is currently working on the research report for International Seaways, Inc. (NYSE: INSW), which also belongs to the Services sector as the Company MAXIMUS. Do not miss out and become a member today for free to access this upcoming report at: is focused on giving you timely information and the inside line on companies that matter to you. This morning, MAXIMUS most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

Earnings Highlights and Summary

For the first quarter of the fiscal year 2018, MAXIMUS' revenues grew 3% to $623.1 million compared to $607.6 million in Q1 FY17. The increase was driven by revenue increases in the Company's Health Services and Human Services segments, including favorable foreign exchange movements. The Company's revenue numbers lagged analysts' estimates of $630.2 million.

During Q1 FY18, MAXIMUS' operating margin improved 70 basis points (bps) to 12.8% compared to the prior year's same period.

For Q1 FY18, MAXIMUS' net income attributable to common shareholders totaled $59.1 million, or $0.89 per diluted share, compared to $46.7 million, or $0.71 per diluted share, in Q1 FY17. The passage of the Tax Cuts and Jobs Act 2017 (TCJA) on December 22, 2017, in the United States created significant benefits for MAXIMUS. Excluding the benefits from the TCJA, the Company's earnings would have been $0.78 per diluted share for the reported quarter. MAXIMUS' earnings numbers came in ahead of Wall Street's estimates of $0.77 per share.

Segment Results

During Q1 FY18, MAXIMUS' Health Services segment's revenues rose 3% to $352.1 million compared to $340.7 million in Q1 FY17, driven by an organic growth and favorable currency exchange movements. The segment's operating margin was 16.4% for the reported quarter compared to 14.7% in the prior year's same period. The operating margin expansion reflected a portfolio of contracts at varying stages of maturity, as well as improved service delivery on the Health Assessment Advisory Service contract compared to Q1 FY17.

For Q1 FY18, MAXIMUS' US Federal Services segment's revenues fell 6% to $133.0 million compared to $141.3 million in Q1 FY17. The lower revenue was largely due to some contracts that ended, including the wind down of the Company's subcontract supporting a program with the US Department of Veterans Affairs. The segment's operating margin was 12.6% in the reported quarter versus 12.7% in the year earlier comparable quarter.

MAXIMUS' Human Services segment's revenues advanced 10% to $138.1 million in Q1 FY18 compared to $125.5 million in Q1 FY17, driven by higher levels of pass-through revenues from the Company's Australian operations, and to a lesser extent, favorable foreign exchange movements. The segment's operating margin was 5.8% for the reported quarter compared to 9.4% in the year earlier corresponding quarter. The operating margin was unfavorably impacted by a number of new contracts that are in the start-up phase, and the aforementioned pass-through revenue in Australia.

Sales and Pipeline

MAXIMUS' year-to-date signed contract awards at December 31, 2017, totaled $1.2 billion and contracts pending (awarded but unsigned) totaled $236.0 million. The Company's sales pipeline was $3.2 billion at December 31, 2017, comprising of approximately $1.0 billion in proposals pending, $0.2 billion in proposals in preparation, and $1.9 billion in opportunities tracking.

Cash Matters

As of December 31, 2017, MAXIMUS' cash and cash equivalents totaled $196.9 million. For Q1 FY18, the Company's cash flows from operations was $37.9 million, with a free cash flow of $31.4 million.

At December 31, 2017, MAXIMUS' days sales outstanding (DSO) were 69, consistent with the previous year.


For the full fiscal year 2018, MAXIMUS re-affirmed its revenue forecasts to be in the range of $2.475 billion and $2.550 billion. The Company raised its fiscal 2018 earnings guidance and now expects GAAP earnings per diluted share to range between $3.30 and $3.50 compared to the Company's prior guidance of $2.95 to $3.15.

Stock Performance Snapshot

March 13, 2018 - At Tuesday's closing bell, MAXIMUS's stock was marginally down 0.34%, ending the trading session at $67.97.

Volume traded for the day: 403.65 thousand shares.

Stock performance in the last month – up 6.55%; previous six-month period – up 8.28%; and past twelve-month period – up 10.97%

After yesterday's close, MAXIMUS's market cap was at $4.48 billion.

Price to Earnings (P/E) ratio was at 22.99.

The stock has a dividend yield of 0.26%.

The stock is part of the Services sector, categorized under the Business Services industry.



Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:


Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

Latest News
Top News